0       0

Long Term Care Medicine-2011


C57 - Limiting the Impact of Antibiotic Resistance in Nursing Homes


Mar 26, 2011 2:30pm ‐ Mar 26, 2011 3:30pm

Standard: $24.00

Description

Accreditation
The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement:
The American Medical Directors Association designates
this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMDCP Credit Designation:
This session has been approved for a total of 1.0 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).

Session Description:
We face an apocalypse of antibiotic resistance. In many facilities Quinolones are becoming ineffective. In a report of 121 nursing home residents with pneumonia and an identified pathogen, MRSA, Pseudomonas, or ESBL producing bacteria were isolated in 72%. Antibiotic resistance varies between facilities. Each facility should maintain a bacteriology database sorted by nursing unit, organism, and date. The database will identify clustering of facility-acquired multi-drug resistant organism (MDRO) in time/space (evidence of transmission) and determine burden of MDROs such as percent of urine or sputum isolates that are antibiotic resistance to quinolones. This information will assist selecting empiric antibiotics for serious illness. This session will present a multifaceted intervention to limit the impact of antibiotic resistance in nursing homes.

Learning Objectives(s):

  • Discuss the value of a facility specific bacteriology database.
  • Describe the surprising similarities between CDC recommendations for Standard and Contact Isolation Precautions in Nursing Homes.
  • Discuss programs to prevent colonizing bacteria from causing infection.
  • Discuss components of a program to prevent the unnecessary use of antibiotics.

Speakers(s):
Paul Drinka, MD, CMD

Disclosure(s):
Paul Drinka, MD, CMD has no financial disclosures to report.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content